Who Created the Largest EBITDA Among Czech Pharmaceutical Companies in 2017?

Top Companies by EBITDA (CZK mil)
Pharmaceutical | Czech Republic | February 23, 2019
$1.99
Excel Sheet

Based on a comparison of 9 firms among Czech Pharmaceutical Companies, Bayer Czech Republic generated the highest earnings before interest cost, taxes and depreciation (so called EBITDA) in 2017 followed by Pfizer Czech Republic and Novartis Czech Republic.

Bayer Czech Republic made EBITDA of CZK 158 mil, down 32.3% compared to the previous year. Historically, the firm’s EBITDA reached an all time high of CZK 233 mil in 2016 and an all time low of CZK -10.0 mil in 2007. The average profit in the last five years amounted to CZK 167 mil.

The company generated an average EBITDA margin of 4.11% for its shareholders in the last five years with a maximum of 5.38% and a minimum of 3.53%.

Comparing Bayer Czech Republic with its closest peers, Pfizer Czech Republic generated EBITDA of CZK 156 mil with a EBITDA margin of 4.36% in 2017, Novartis Czech Republic grossed CZK 138 mil (EBITDA margin of 2.18%) and GlaxoSmithKline Czech Republic announced a profit of CZK 97.4 mil translating into a margin of 3.36%.

You can see all the companies ebitda data on the EBITDA indicator page or you can download a special statistical dossier on the Czech Pharmaceutical Companies in the reports section.

EBITDA Unit 2010 2011 2012 2013 2014 2015 2016 2017
Roche Czech Republic CZK mil 208 204 328 265 209 ...
Merck Czech Republic CZK mil 67.1 83.8 49.2 53.6 95.9
Amgen Czech Republic CZK mil 58.3 37.3 41.1 54.4 46.3
Pfizer Czech Republic CZK mil 316 66.4 173 172 110
Bayer Czech Republic CZK mil 168 112 135 143 168
GlaxoSmithKline Czech Republic CZK mil 310 234 189 139 139
Sanofi-Aventis Czech Republic CZK mil 90.8 80.9 98.9 17.0 94.6
Novartis Czech Republic CZK mil 61.6 69.8 71.6 113 131
Servier Czech Republic CZK mil ... ... 19.2 20.1 20.8 23.8
AVERAGE CZK mil 128 160 101 123 109 113 134 94.2